$14.49
At close: May 5 EDT
$14.49
0.000.00%
Pre-Market: 4:01 PM EDT
Comments
Loading...
Anika Therapeutics Stock Guidance | NASDAQ:ANIK | Benzinga
Anika Therapeutics issues guidance on future EPS and revenue, giving investors insight into how much the company expects to earn in upcoming periods.
| Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| 08/08/2024 | ANIK | Anika Therapeutics | FY | 2024 | — | — | — | $168.00M | $173.00M | $170.84M | Get Alert |
| 05/08/2024 | ANIK | Anika Therapeutics | FY | 2024 | — | — | — | $168.00M | $173.00M | $170.27M | Get Alert |
| 03/13/2024 | ANIK | Anika Therapeutics | FY | 2024 | — | — | — | $168.00M | $173.00M | $179.42M | Get Alert |
| 11/02/2023 | ANIK | Anika Therapeutics | FY | 2023 | — | — | — | $164.00M | $166.00M | $161.29M | Get Alert |
| 08/08/2023 | ANIK | Anika Therapeutics | FY | 2023 | — | — | — | $159.50M | $163.00M | $161.84M | Get Alert |
| 05/09/2023 | ANIK | Anika Therapeutics | FY | 2023 | — | — | — | $158.00M | $163.00M | $161.06M | Get Alert |
| 03/06/2023 | ANIK | Anika Therapeutics | FY | 2023 | — | — | — | $158.00M | $163.00M | $168.40M | Get Alert |
| 11/04/2021 | ANIK | Anika Therapeutics | FY | 2021 | — | — | — | $142.20M | $144.81M | $147.52M | Get Alert |
| 08/05/2021 | ANIK | Anika Therapeutics | FY | 2021 | — | — | — | $144.81M | $148.72M | $144.15M | Get Alert |
| 06/03/2021 | ANIK | Anika Therapeutics | FY | 2021 | — | — | — | $143.50M | $147.42M | $144.15M | Get Alert |
FAQ
What is the most recent guidance for Anika Therapeutics (ANIK)?
There have been no specific sales or earnings guidance reported for Anika Therapeutics in recent months.
Browse guidance and forecast on all stocks.
